Marc Schwabish
Chief Business Officer
Bio:
Marc is CBO at Tectonic Therapeutic. He joined the company when it was private and helped lead its financings (including its reverse merger with AVROBIO) and advance the company from a preclinical to a clinical-stage organization. Previously, Marc was SVP Business Development and US Operations at Fusion Pharma where his transactions included the company’s Series B, IPO, and an expansive partnership with AstraZeneca. Earlier in his career, Marc served as Head of US Pharma Business Development at Bayer, held roles in Business Development and Alliance Management at Eisai. He began his career in Strategy Consulting at Leerink Swann (now Guidehouse), and Healthcare Investment Banking at RBS. Marc has led deals across various therapeutic areas; from early technologies to commercialized assets; buy-side, sell-side, partnerships, and financings; and a mix of deal/financing structures. He holds a PhD in Biochemistry and Molecular Pharmacology from Harvard and a BS in Biology from Cornell.